Elizabeth Crowley
Corporate Officer/Principal bei CELLDEX THERAPEUTICS, INC.
Vermögen: 198 350 $ am 31.03.2024
Profil
Elizabeth Crowley is currently the Director at Horizons for Homeless Children, Inc. She is also currently serving as the Chief Product Development Officer & Senior VP at Celldex Therapeutics, Inc. She previously worked as the Director-Global Study Audit Management at Bayer Corp.
and as the Vice President-Development Operations at CuraGen Corp.
Ms. Crowley completed her undergraduate degree at Boston College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.06.2023 | 4 726 ( 0,01% ) | 198 350 $ | 31.03.2024 |
Aktive Positionen von Elizabeth Crowley
| Unternehmen | Position | Beginn |
|---|---|---|
| CELLDEX THERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2009 |
Horizons for Homeless Children, Inc.
 Horizons for Homeless Children, Inc. Miscellaneous Commercial ServicesCommercial Services Horizons for Homeless Children, Inc. operates as a day care center. The company was founded by Roger H. Brown, Michael Richard Eisenson and Linda A. Mason and is headquartered in Roxbury, MA. | Director/Board Member | - |
Ehemalige bekannte Positionen von Elizabeth Crowley
| Unternehmen | Position | Ende |
|---|---|---|
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Corporate Officer/Principal | - |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Corporate Officer/Principal | - |
Ausbildung von Elizabeth Crowley
| Boston College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CELLDEX THERAPEUTICS, INC. | Health Services |
| Private Unternehmen | 3 |
|---|---|
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Health Technology |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
Horizons for Homeless Children, Inc.
Horizons for Homeless Children, Inc. Miscellaneous Commercial ServicesCommercial Services Horizons for Homeless Children, Inc. operates as a day care center. The company was founded by Roger H. Brown, Michael Richard Eisenson and Linda A. Mason and is headquartered in Roxbury, MA. | Commercial Services |
